Neovasc Inc (NVCN) Return on Equity ROE from the fourth quarter 2021 to fourth quarter 2019 and annually, average high and low, overall ranking from Dec 31 2021 to Dec 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neovasc Inc   (NASDAQ: NVCN)

Neovasc Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Neovasc Inc in the fourth quarter 2021?
Neovasc Inc recorded a cumulative net loss of $-25 million during 12 months ending in the fourth quarter 2021, resulting in a negative return on equity (ROE) of -47.65%.

Within the Medical Equipment & Supplies industry 132 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2021 from 0 to 3907.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Equity Change 2541.1 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -25 -35 -35 -35 -35
Return On Equity (TTM) -47.65 % -88.57 % -152.76 % -555.12 % -
NVCN's Total Ranking # 3907 # 0 # 0 # 0 #
Equity (TTM) in Millions 52 52 52 52 2
Seq. Equity Change 0 % 0 % 0 % 2541.1 % -
Seq. Net Income Change - - - - -

Back to NVCN Management Effectiveness >> NVCN's 5 Years Annual ROE >> Compare NVCN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 133
Sector # 574
Overall # 3907

Return On Equity Statistics
High Average Low
-47.65 %
-47.65 %
-47.65 %
(Dec 31 2021)  





NVCN Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2015)
2017
Total Equity in Millions 52 2 -14 -8 -35
Y / Y Equity Change 2541.1 % - - - -
Net Income in Millions -25 -29 -35 -108 -22
Y / Y Net Income Change - - - - -
Return On Equity -47.65 % -1451.06 % - - -

Back to NVCN Management Effectiveness >> NVCN's 5 Years Annual ROE >> Compare NVCN ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NVCN's' Return on Equity at Yahoo Finance
NVCN's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NVCN's Competitors
Subscribers only: Roe for Neovasc Inc 's Suppliers
Subscribers only: Return On Equity for NVCN's Customers




Companies with similar Return On Equity at Dec 31 2021, within Healthcare Sector ROE

Date modified: 2023-03-24T17:08:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.